Rapid 366 turnover of plasma virions and CD4 lymphocytes in HIV-1 infection, Nature, vol.373, issue.6510, pp.123-129, 1995. ,
Viral dynamics 369 in human immunodeficiency virus type 1 infection, Nature, vol.373, issue.6510, pp.117-370, 1995. ,
Introduction to modeling viral infections and immunity ,
, Immunological Reviews, vol.285, issue.1, pp.5-8, 2018.
, Modelling viral and immune system dynamics, Nat Rev Immunol, vol.2, issue.1, pp.28-36, 2002374-01.
Mathematical modeling of within-host Zika virus dynamics ,
, Immunological Reviews, vol.285, issue.1, pp.81-96, 2018.
Modeling the dynamics of hepatitis B infection, immunity, and drug therapy ,
, Immunological Reviews, vol.285, issue.1, pp.38-54, 2018.
Estimation of population pharmacokinetic parameters of 380 saquinavir in HIV patients with the MONOLIX software, J Pharmacokinet, vol.381, issue.2, pp.229-278, 2007. ,
Practical identifiability of HIV dynamics models, Bulletin of Mathematical Biology, vol.383, issue.8, pp.2493-513, 2007.,
URL : https://hal.archives-ouvertes.fr/inserm-00204273
A 385 comprehensive Hepatitis C viral kinetic model explaining cure, Clinical Pharmacology, vol.386, issue.6, pp.706-719, 2010. ,
HCV kinetic models and their implications in drug development: 388 HCV kinetic models and their implications, vol.4, pp.231-273, 2015. ,
Towards a quantitative understanding of the within-host 391 dynamics of influenza A infections, Journal of The Royal Society Interface, vol.7, issue.42, pp.35-47, 2010. ,
, Kinetics of coinfection with influenza A virus and streptococcus pneumoniae, vol.9, p.1003238, 2013.
, Strong inference in mathematical modeling: a method for robust science in 397 the twenty-first century. Frontiers in Microbiology, vol.7, p.13, 2016.
Model selection: an integral part of inference ,
, Biometrics, vol.53, issue.2, p.603, 1997.
, Ten simple rules for reducing overoptimistic reporting in 403 methodological computational research. Lewitter F, editor. PLOS Computational 404 Biology, vol.11, p.1004191, 2015.
Systems biology (un)certainties. Science, vol.350, pp.386-394, 2015406-10-23. ,
Model selection and multimodel inference: a practical 408 information-theoretic approach. 2, vol.409, p.p, 2010. ,
Model selection and model averaging, p.411, 2008. ,
Zika plasma 414 viral dynamics in nonhuman primates provides insights into early infection and antiviral 415 strategies, Proceedings of the National Academy of Sciences, vol.114, pp.8847-52, 2017. ,
Ebola viral 418 dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and 419 antiviral strategies, Nature Communications, vol.9, issue.1, 2018. ,
Comparison of model-based tests and selection 421 strategies to detect genetic polymorphisms influencing pharmacokinetic parameters, Journal of Biopharmaceutical Statistics, vol.422, issue.6, pp.1084-102, 2008. ,
Model selection and Akaike's Information Criterion (AIC): The general 424 theory and its analytical extensions, Psychometrika, vol.52, issue.3, pp.345-70, 1987. ,
Understanding information criteria for selection among 426 capture-recapture or ring recovery models. Bird Study, vol.46, pp.14-21, 1999. ,
The Bayesian information criterion: background, derivation, 428 and applications: The Bayesian information criterion, WIREs Comp Stat, vol.4, issue.2, pp.199-203, 2012429-03. ,
Comparison of model averaging and 431 model selection in dose finding trials analyzed by nonlinear mixed effect models, AAPS 432 J, vol.20, issue.3, p.56, 201829. ,
Model selection and averaging of 434 nonlinear mixed-effect models for robust phase III dose selection, J Pharmacokinet, vol.435, issue.6, pp.581-97, 2017. ,
A 437 method to determine the duration of the eclipse phase for in vitro infection with a highly 438 pathogenic SHIV strain. Sci Rep, vol.5, p.10371, 2015. ,
Identifiability of nonlinear systems with application to HIV/AIDS 440 models, IEEE Transactions on Automatic Control, vol.48, issue.2, pp.330-336, 2003. ,
, , p.442
, HIV/AIDS dynamic models, Bulletin of Mathematical Biology, vol.70, issue.3, pp.785-99, 2008.
Modeling 444 and estimation of kinetic parameters and replicative fitness of HIV-1 from flow-445 cytometry-based growth competition experiments, Bulletin of Mathematical Biology, vol.446, issue.6, pp.1749-71, 2008. ,
PFIM 4.0, 448 an extended R program for design evaluation and optimization in nonlinear mixed-effect 449 models, Computer Methods and Programs in Biomedicine, vol.156, pp.217-246, 2018.,
URL : https://hal.archives-ouvertes.fr/inserm-01698017
Kinetics of influenza 451 A virus infection in humans, J Virol, vol.80, issue.15, pp.7590-7599, 2006. ,
Modeling 453 within-host dynamics of influenza virus infection including immune responses, p.454 ,
, Comput Biol, vol.8, issue.6, 2012.
Model-based dose finding under model 457 uncertainty using general parametric models, Statist Med, vol.33, issue.10, pp.1646-61, 2014. ,
Model selection versus model averaging in 459 dose finding studies: K. SCHORNING ET AL, Statistics in Medicine, vol.35, issue.22, pp.4021-4061, 2016. ,
, Dynamics of influenza virus infection and pathology, J Virol, vol.84, issue.8, pp.3974-83, 2010.
Bayesian model averaging: a tutorial. Statist 464 Sci, vol.14, pp.382-417, 1999. ,
Model selection and multimodel inference: a practical 466 information-theoretic approach. 2, vol.467, p.p, 2010. ,
The dependence of viral parameter estimates on the assumed viral life cycle: 469 limitations of studies of viral load data, Proceedings: Biological Sciences, vol.470, pp.847-54, 1469. ,
Estimation of the initial 472 viral growth rate and basic reproductive number during acute HIV-1 infection, Journal of 473 Virology, vol.84, issue.12, pp.6096-102, 2010. ,
, Figure 1. Viral kinetics profiles obtained with the population parameters for each 495 candidate model. (A) and (B) correspond to the simulation settings I and II, respectively, p.496
, At left, the first 3 curves correspond to models with k = 497 20 d -1 ; center, models with k = 4 d -1 and right, models with k = 1 d -1 . Within each group